Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

60 Degrees Pharmaceuticals (SXTP) Notes Payables (2022 - 2023)

60 Degrees Pharmaceuticals (SXTP) has disclosed Notes Payables for 2 consecutive years, with $2.2 million as the latest value for Q3 2023.

  • On a quarterly basis, Notes Payables changed N/A to $2.2 million in Q3 2023 year-over-year; TTM through Sep 2023 was $2.2 million, a N/A change, with the full-year FY2022 number at $16.9 million, changed N/A from a year prior.
  • Notes Payables was $2.2 million for Q3 2023 at 60 Degrees Pharmaceuticals, up from $1.1 million in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $16.9 million in Q4 2022 to a low of $1.1 million in Q2 2023.